Curis CRIS
NASDAQ CRIS
$0.40 +0.01 (+3.29%)
At close: Oct 22, 2026 · 4:00 PM EDT

Curis (CRIS) EV to CFO (2012)

Updated

Curis' EV to CFO was 42.42 in Q3 2012, down 27.4% from the prior quarter.

Analysis

Curis (CRIS) EV to CFO (2012) Analysis & Trends

On a trailing twelve-month basis, Curis' EV to CFO was 23.77 through Sep 30, 2012.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 Curis 862,692.43 -33.32 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2012 42.42
Jun 30, 2012 58.40
Mar 31, 2012 83.50
API Access

Curis EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=CRIS&period=max&api_key=YOUR_API_KEY